LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 21 of 497
Next
>>
>
501 to 525 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	GSK1059615	0.12	uM	LJP6	3	C05	72	hr	1657	2780	5505	0.5049	0.2917
BT-20	GSK1904529A	0.12	uM	LJP6	1	H23	72	hr	1657	4571	5505	0.8302	0.7571
BT-20	GSK1904529A	0.12	uM	LJP6	2	H23	72	hr	1657	5004	5505	0.9089	0.8696
BT-20	GSK1904529A	0.12	uM	LJP6	3	H23	72	hr	1657	5056	5505	0.9183	0.8831
BT-20	Omipalisib	0.12	uM	LJP6	1	N05	72	hr	1657	1363	5505	0.2476	-0.0766
BT-20	Omipalisib	0.12	uM	LJP6	2	N05	72	hr	1657	1351	5505	0.2454	-0.0797
BT-20	Omipalisib	0.12	uM	LJP6	3	N05	72	hr	1657	1600	5505	0.2907	-0.0149
BT-20	GSK 690693	0.12	uM	LJP5	1	F23	72	hr	1657	4818	5505	0.8751	0.8213
BT-20	GSK 690693	0.12	uM	LJP5	2	F23	72	hr	1657	4172	5505	0.7578	0.6534
BT-20	GSK 690693	0.12	uM	LJP5	3	F23	72	hr	1657	4807	5505	0.8731	0.8184
BT-20	GW843682X	0.12	uM	LJP6	1	B17	72	hr	1657	3418	5505	0.6208	0.4575
BT-20	GW843682X	0.12	uM	LJP6	2	B17	72	hr	1657	3364	5505	0.6110	0.4434
BT-20	GW843682X	0.12	uM	LJP6	3	B17	72	hr	1657	3647	5505	0.6624	0.5170
BT-20	HG-5-113-01	0.12	uM	LJP5	1	B11	72	hr	1657	5031	5505	0.9138	0.8766
BT-20	HG-5-113-01	0.12	uM	LJP5	2	B11	72	hr	1657	4861	5505	0.8829	0.8325
BT-20	HG-5-113-01	0.12	uM	LJP5	3	B11	72	hr	1657	5125	5505	0.9309	0.9011
BT-20	HG-5-88-01	0.12	uM	LJP6	1	A23	72	hr	1657	5003	5505	0.9087	0.8694
BT-20	HG-5-88-01	0.12	uM	LJP6	2	A23	72	hr	1657	5262	5505	0.9557	0.9367
BT-20	HG-5-88-01	0.12	uM	LJP6	3	A23	72	hr	1657	5546	5505	1.0073	1.0105
BT-20	Imatinib	0.12	uM	LJP6	1	N17	72	hr	1657	5555	5505	1.0090	1.0128
BT-20	Imatinib	0.12	uM	LJP6	2	N17	72	hr	1657	5992	5505	1.0883	1.1264
BT-20	Imatinib	0.12	uM	LJP6	3	N17	72	hr	1657	5729	5505	1.0406	1.0580
BT-20	JNK-9L	0.12	uM	LJP6	1	K23	72	hr	1657	4159	5505	0.7554	0.6500
BT-20	JNK-9L	0.12	uM	LJP6	2	K23	72	hr	1657	4223	5505	0.7670	0.6667
BT-20	JNK-9L	0.12	uM	LJP6	3	K23	72	hr	1657	4051	5505	0.7358	0.6220

|<
<<
Previous
Page 21 of 497
Next
>>
>
501 to 525 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)